• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西淋病奈瑟菌分离株中喹诺酮类耐药的分子特征。

Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.

机构信息

Instituto de Microbiologia Paulo de Góes/UFRJ, Centro de Ciências da Saúde, Bloco I, Ilha do Fundão, Rio de Janeiro 21941-590, Brazil.

出版信息

J Clin Microbiol. 2011 Dec;49(12):4208-12. doi: 10.1128/JCM.01175-11. Epub 2011 Oct 5.

DOI:10.1128/JCM.01175-11
PMID:21976763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232978/
Abstract

Despite the rapid spread of antibiotic resistance among gonococci worldwide, limited reports are available from Brazilian locations. In the present study, 25 quinolone-resistant Neisseria gonorrhoeae (QRNG) strains isolated in Rio de Janeiro, Brazil, were characterized by phenotypic and molecular methods, including analysis of mutations in the gyrA and parC genes. They represented 16.5% of the N. gonorrhoeae isolates obtained during a survey performed from 2006 to 2010. A trend for increasing resistance to ciprofloxacin was observed in the period investigated. The most prevalent pattern of mutation observed among QRNG isolates, Ser-91 to Phe and Asp-95 to Gly in gyrA and Ser-87 to Arg in parC, was detected in 40% of the isolates exhibiting MICs ranging from 4 to >32 μg/ml. Rare types of mutations were found in the gyrA gene (Gln-102 to His [12%] and Asp-95 to Tyr [4%]) and in the parC gene (Ser-88 to Thr [4%]). The genetic relationship of the QRNG isolates, evaluated by pulsed-field gel electrophoresis, suggested that the increase in the frequencies of the QRNG isolates in Rio de Janeiro, Brazil, may have arisen as a result of simultaneous spread of two clonal groups. The results also indicate that fluoroquinolones may no longer be used as first line antibiotics for the treatment of gonorrhea in Rio de Janeiro, and that programs for antimicrobial susceptibility surveillance of N. gonorrhoeae should also be implemented in other regions of Brazil.

摘要

尽管全球淋病奈瑟菌对抗生素的耐药性迅速传播,但来自巴西的报告有限。在本研究中,通过表型和分子方法对从巴西里约热内卢分离的 25 株耐喹诺酮淋病奈瑟菌(QRNG)进行了特征描述,包括对 gyrA 和 parC 基因突变的分析。它们代表了 2006 年至 2010 年期间进行的一项调查中获得的淋病奈瑟菌分离株的 16.5%。在调查期间,观察到对环丙沙星的耐药性呈上升趋势。在 QRNG 分离株中观察到的最常见突变模式是 gyrA 中的 Ser-91 到 Phe 和 Asp-95 到 Gly,以及 parC 中的 Ser-87 到 Arg,在 40%的 MIC 范围为 4 至 >32μg/ml 的分离株中检测到。在 gyrA 基因(Gln-102 到 His [12%]和 Asp-95 到 Tyr [4%])和 parC 基因(Ser-88 到 Thr [4%])中发现了罕见的突变类型。通过脉冲场凝胶电泳评估 QRNG 分离株的遗传关系表明,巴西里约热内卢 QRNG 分离株频率的增加可能是由于两个克隆群的同时传播所致。结果还表明,氟喹诺酮类药物可能不再适用于里约热内卢淋病的一线治疗,并且还应在巴西其他地区实施淋病奈瑟菌抗菌药物敏感性监测计划。

相似文献

1
Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.巴西淋病奈瑟菌分离株中喹诺酮类耐药的分子特征。
J Clin Microbiol. 2011 Dec;49(12):4208-12. doi: 10.1128/JCM.01175-11. Epub 2011 Oct 5.
2
Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.印度耐喹诺酮淋病奈瑟菌分离株中 gyrA 和 parC 基因突变。
Int J Antimicrob Agents. 2012 Dec;40(6):549-53. doi: 10.1016/j.ijantimicag.2012.08.007. Epub 2012 Oct 11.
3
Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak.引起加利福尼亚感染暴发的耐氟喹诺酮淋病奈瑟菌的菌株分型及抗菌药物耐药性
J Clin Microbiol. 2009 Sep;47(9):2944-9. doi: 10.1128/JCM.01001-09. Epub 2009 Jul 22.
4
Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.2000 年至 2006 年韩国淋病奈瑟菌分离株的抗菌药物耐药趋势。
Sex Transm Dis. 2011 Nov;38(11):1082-6. doi: 10.1097/OLQ.0b013e31822e60a4.
5
Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.在韩国及周边国家分离出的耐氟喹诺酮淋病奈瑟菌菌株的流行病学特征和分子基础。
J Antimicrob Chemother. 2004 Aug;54(2):451-5. doi: 10.1093/jac/dkh345. Epub 2004 Jul 1.
6
gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.肯尼亚淋病奈瑟菌氟喹诺酮耐药株中 gyrA 和 parC 突变。
BMC Microbiol. 2019 Apr 8;19(1):76. doi: 10.1186/s12866-019-1439-1.
7
Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.天然存在的喹诺酮耐药淋病奈瑟菌菌株对新型喹诺酮类药物的体外敏感性与GyrA和ParC变化的相关性
Antimicrob Agents Chemother. 2001 Mar;45(3):734-8. doi: 10.1128/AAC.45.3.734-738.2001.
8
Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.加拿大淋病奈瑟菌分离株中环丙沙星耐药性的特征分析
Sex Transm Dis. 2002 Dec;29(12):780-8. doi: 10.1097/00007435-200212000-00008.
9
High-frequency of quinolone-resistant Neisseria gonorrhoeae in Austria with a common pattern of triple mutations in GyrA and ParC genes.奥地利淋病奈瑟菌喹诺酮耐药性高发,其GyrA和ParC基因存在常见的三联突变模式。
Sex Transm Dis. 2004 Oct;31(10):616-8. doi: 10.1097/01.olq.0000140019.18390.28.
10
Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.2002 年至 2009 年期间,肯尼亚基苏木的一组年轻男性淋病奈瑟菌分离株中出现了喹诺酮类药物耐药和头孢菌素 MIC 攀升现象。
Antimicrob Agents Chemother. 2011 Aug;55(8):3882-8. doi: 10.1128/AAC.00155-11. Epub 2011 May 23.

引用本文的文献

1
The frequency of mutations in the A, R, A and C genes of , the presence of M gene and antibiotic resistance/susceptibility: a systematic review and meta-analyses.[某种生物]的A、R、A和C基因中的突变频率、M基因的存在情况以及抗生素耐药性/敏感性:一项系统综述和荟萃分析。
Front Microbiol. 2025 Jan 22;15:1414330. doi: 10.3389/fmicb.2024.1414330. eCollection 2024.
2
Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.拉美国家淋病奈瑟菌的耐药性:系统评价。
J Antimicrob Chemother. 2023 Jun 1;78(6):1322-1336. doi: 10.1093/jac/dkad071.
3
Penicillinase plasmid Australia type in Neisseria gonorrhoeae isolated in Poland.在波兰分离的淋病奈瑟菌中存在青霉素酶质粒澳大利亚型。
Arch Microbiol. 2022 Jan 9;204(2):130. doi: 10.1007/s00203-021-02623-w.
4
Persistence Dynamics of Antimicrobial-Resistant in the Pharynx of Rhesus Macaques.恒河猴咽部抗菌药物耐药性的持续动态变化
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.02232-19.
5
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.耐多药淋病奈瑟菌:二十一世纪第二个十年的新威胁。
Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4.
6
Temporal evolution of antimicrobial resistance among Neisseria gonorrhoeae clinical isolates in the most populated South American Metropolitan Region.南美人口最密集大都市地区淋病奈瑟菌临床分离株中抗菌药物耐药性的时间演变
Mem Inst Oswaldo Cruz. 2019;114:e190079. doi: 10.1590/0074-02760190079. Epub 2019 Aug 12.
7
Phylogeny and antimicrobial resistance in Neisseria gonorrhoeae isolates from Rio de Janeiro, Brazil.巴西里约热内卢淋病奈瑟菌分离株的系统发育和抗菌耐药性。
Infect Genet Evol. 2018 Mar;58:157-163. doi: 10.1016/j.meegid.2017.12.003. Epub 2017 Dec 7.
8
Exploring quinolone resistance-determining region in isolates from across India.探索来自印度各地的 分离株中的喹诺酮耐药决定区。
Indian J Med Res. 2017 Jul;146(Supplement):S64-S69. doi: 10.4103/ijmr.IJMR_730_15.
9
Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated by Stepwise Selection.氟喹诺酮类耐药卡他莫拉菌变异株的逐步选择与分子特征
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01336-17. Print 2017 Oct.
10
Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat.淋病奈瑟菌的抗菌药物耐药性:一种新出现的全球威胁的历史、分子机制及流行病学方面
Braz J Microbiol. 2017 Oct-Dec;48(4):617-628. doi: 10.1016/j.bjm.2017.06.001. Epub 2017 Jul 12.

本文引用的文献

1
Prevalence of Neisseria gonorrhoeae and Chlamydia trachomatis infection in men attending STD clinics in Brazil.巴西性传播疾病门诊男性就诊者中淋病奈瑟菌和沙眼衣原体感染的流行情况。
Rev Soc Bras Med Trop. 2010 Sep-Oct;43(5):500-3. doi: 10.1590/s0037-86822010000500005.
2
Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants.意大利分离的淋病奈瑟菌菌株对环丙沙星的耐药趋势及分子决定因素分析
Diagn Microbiol Infect Dis. 2010 Aug;67(4):350-4. doi: 10.1016/j.diagmicrobio.2010.03.001.
3
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008.2007 - 2008年世界卫生组织西太平洋和东南亚地区淋病奈瑟菌抗生素耐药性监测
Commun Dis Intell Q Rep. 2010 Mar;34(1):1-7. doi: 10.33321/cdi.2010.34.1.
4
Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece.在希腊分离的淋病奈瑟菌中,抗菌药物敏感性和血清型分布的变化情况。
Sex Transm Dis. 2010 Feb;37(2):115-20. doi: 10.1097/OLQ.0b013e3181bcd0b8.
5
[Prevalence of Chlamydia and Neisseria gonorrhoeae infections in pregnant women in six Brazilian cities].[巴西六个城市孕妇沙眼衣原体和淋病奈瑟菌感染的患病率]
Rev Bras Ginecol Obstet. 2008 Dec;30(12):614-9. doi: 10.1590/s0100-72032008001200005.
6
Multidrug-resistant Neisseria gonorrhoeae.多重耐药淋病奈瑟菌
CMAJ. 2009 Feb 3;180(3):268-9. doi: 10.1503/cmaj.081721.
7
Mutations in gyrA and parC in ciprofloxacin-resistant Neisseria gonorrhoeae in Kuala Lumpur, Malaysia.马来西亚吉隆坡耐环丙沙星淋病奈瑟菌中gyrA和parC的突变
J Antimicrob Chemother. 2007 Apr;59(4):803-4. doi: 10.1093/jac/dkm016. Epub 2007 Feb 28.
8
Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu Province, China, with a focus on fluoroquinolone resistance.中国江苏省分离的淋病奈瑟菌的抗菌药敏性,重点关注氟喹诺酮耐药性。
J Med Microbiol. 2006 Sep;55(Pt 9):1251-1255. doi: 10.1099/jmm.0.46401-0.
9
Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.运用寡核苷酸生物芯片技术检测淋病奈瑟菌中与环丙沙星耐药相关的gyrA和parC突变
J Clin Microbiol. 2004 Dec;42(12):5819-24. doi: 10.1128/JCM.42.12.5819-5824.2004.
10
Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.在韩国及周边国家分离出的耐氟喹诺酮淋病奈瑟菌菌株的流行病学特征和分子基础。
J Antimicrob Chemother. 2004 Aug;54(2):451-5. doi: 10.1093/jac/dkh345. Epub 2004 Jul 1.